Up to $150,000 in grant funding available for beef and dairy studies
Zoetis, formerly Pfizer Animal Health, announces the return of the Cattle Call grant program and is accepting research proposals for improving cattle reproduction or developing models for managing cattle pain.
The Cattle Call supports the development of new products and services that improve the health and productivity of beef and dairy cattle. In 2013, Zoetis will fund one or more researchers with a grant of up to $150,000, with minimum funding of $25,000.
"The inaugural Cattle Call grant program in 2012 successfully brought forth many new ideas and technologies that are helping to address important needs in the veterinary and cattle industries," says Michelle Haven, PhD, senior vice president, corporate development, alliances and solutions, Zoetis. "We are very excited about the research we helped fund for improving productivity and immune function in cattle, and we look forward to building on our partnerships to expand research into reproduction and pain management in 2013."
Innovations in research would not be possible without partnerships with industry experts, Dr. Haven says.
"At Zoetis, we're dedicated to research collaborations that benefit all livestock," she says. "The 2013 Cattle Call program will bring together research perspectives from across the cattle industry to advance our mission to continuously improve the health and care of animals worldwide and to advance veterinary science and education."
For more information about the 2013 Cattle Call program or to obtain an application, contact email@example.com. The application deadline is April 30, 2013. All applicants must be in good standing in their professional organizations (e.g., American Association of Bovine Practitioners, American Dairy Science Association, etc.). Research must be conducted in the United States. Candidates will be notified of the research committee's decision by May 31, 2013.
Zoetis (z?-EH-tis) is the leading animal health company, dedicated to supporting its customers and their businesses. Building on a 60-year history as the animal health business of Pfizer, Zoetis discovers, develops, manufactures and markets veterinary vaccines and medicines, with a focus on both farm and companion animals. The company generated annual revenue of $4.2 billion in fiscal 2011. Zoetis has more than 9,500 employees and a local presence in approximately 70 countries, including 29 manufacturing facilities in 11 countries. Its products serve veterinarians, livestock producers and people who raise and care for farm and companion animals in 120 countries.